Literature DB >> 21653222

Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth.

Pernille Hojman1, Christine Dethlefsen, Claus Brandt, Jakob Hansen, Line Pedersen, Bente Klarlund Pedersen.   

Abstract

Regular physical activity protects against the development of breast and colon cancer, since it reduces the risk of developing these by 25-30%. During exercise, humoral factors are released from the working muscles for endocrinal signaling to other organs. We hypothesized that these myokines mediate some of the inhibitory effects of exercise on mammary cancer cell proliferation. Serum and muscles were collected from mice after an exercise bout. Incubation with exercise-conditioned serum inhibited MCF-7 cell proliferation by 52% and increased caspase activity by 54%. A similar increase in caspase activity was found after incubation of MCF-7 cells with conditioned media from electrically stimulated myotubes. PCR array analysis (CAPM-0838E; SABiosciences) revealed that seven genes were upregulated in the muscles after exercise, and of these oncostatin M (OSM) proved to inhibit MCF-7 proliferation by 42%, increase caspase activity by 46%, and induce apoptosis. Blocking OSM signaling with anti-OSM antibodies reduced the induction of caspase activity by 51%. To verify that OSM was a myokine, we showed that it was significantly upregulated in serum and in three muscles, tibialis cranialis, gastronemius, and soleus, after an exercise bout. In contrast, OSM expression remained unchanged in subcutaneous and visceral adipose tissue, liver, and spleen (mononuclear cells). We conclude that postexercise serum inhibits mammary cancer cell proliferation and induces apoptosis of these cells. We suggest that one or more myokines secreted from working muscles may be mediating this effect and that OSM is a possible candidate. These findings emphasize that role of physical activity in cancer treatment, showing a direct link between exercise-induced humoral factors and decreased tumor cell growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653222     DOI: 10.1152/ajpendo.00520.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  61 in total

Review 1.  Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exercise-induced immune modulation and exercise-induced myokines.

Authors:  Jorming Goh; Negin Niksirat; Kristin L Campbell
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 3.  The influence of skeletal muscle on systemic aging and lifespan.

Authors:  Fabio Demontis; Rosanna Piccirillo; Alfred L Goldberg; Norbert Perrimon
Journal:  Aging Cell       Date:  2013-07-17       Impact factor: 9.304

Review 4.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  The skeletal muscle secretome: an emerging player in muscle-bone crosstalk.

Authors:  Mark W Hamrick
Journal:  Bonekey Rep       Date:  2012-04-11

6.  Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy.

Authors:  Josua Aponte Serrano; Amit Hagar
Journal:  Cancer Immunol Immunother       Date:  2021-01-08       Impact factor: 6.968

Review 7.  Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations.

Authors:  Christoph Hoffmann; Cora Weigert
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

8.  Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.

Authors:  Kensuke Kudou; Hiroshi Saeki; Yuichiro Nakashima; Koichi Kimura; Koji Ando; Eiji Oki; Tetsuo Ikeda; Yoshihiko Maehara
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 9.  The ever-expanding myokinome: discovery challenges and therapeutic implications.

Authors:  Martin Whitham; Mark A Febbraio
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

10.  Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.